Herman, Talia
Barer, Yael
Bitan, Michal http://orcid.org/0000-0002-9537-7788
Sobol, Shani
Giladi, Nir
Hausdorff, Jeffrey M.
Article History
Received: 11 June 2023
Accepted: 2 November 2023
First Online: 4 December 2023
Competing interests
: T.H., Y.B., S.S. and M.B. have no conflicts of interest. N.G. has received funding from The Michael J Fox Foundation, The National Parkinson Foundation, The European Union and The Israel Science Foundation as well as from Biogen and Ionis, The Sieratzki Family Foundation, and The Aufzien Academic Center in Tel-Aviv University and consulting fees from Sionara, NeuroDerm, and Pharma2B. He has participated on a Data Safety Monitoring Board or Advisory Board of Pharma2B and NeuroDerm and has stock or stock options with GaitBetter LTD. J.M.H. has received grant funding from the US National Institutes of Health, the Israel Ministry of Health, the Michael J Fox Foundation for Parkinson’s Research and the National Multiple Sclerosis Society. He also is supported in part by the Mobilize-D project that has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No. 820820. This JU receives support from the European Union’s Horizon 2020 research and innovation program and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Content in this publication reflects the authors’ view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein. He is also a consultant for F. Hoffman-La Roche Ltd, via Tel Aviv Sourasky Medical Center, and has stock or stock options with GaitBetter LTD. He is also on an advisory board of the Michael J Fox Foundation for Parkinson’s Research (no fee), participated on the task force for global guidelines on falls in older adults, on the Movement Disorders Society Task Force on Technology, on Stanford’s Restore Center advisory board, and on the Scientific Advisory Board of the Tel Aviv University Health Longevity Research Center.